Medical Training AIAutoimmune and Connective Tissue Disease
Recognize and manage systemic lupus, scleroderma, vasculitis, and inflammatory myopathies with a structured, evidence-based approach.
What this track covers
This track covers the recognition, workup, and management of major connective tissue diseases, including systemic lupus erythematosus, scleroderma, vasculitis syndromes, and inflammatory myopathies. It emphasizes classification criteria, autoantibody interpretation, and multi-system disease patterns that shape diagnosis and treatment decisions.
What you will practice
- Distinguish limited versus diffuse scleroderma and their organ involvement patterns
- Apply classification criteria to differentiate SLE from other connective tissue diseases
- Interpret ANA patterns and disease-specific autoantibodies in clinical context
- Classify vasculitis syndromes by vessel size and presentation
- Differentiate dermatomyositis, polymyositis, and immune-mediated necrotizing myopathy
Simulator scenario
A patient presents with new proximal muscle weakness, a rash, and elevated muscle enzymes, requiring the clinician to work through the differential of inflammatory myopathies and select appropriate confirmatory testing.
Board question topics
- SLE classification criteria and disease activity assessment
- Scleroderma subtypes and organ involvement screening
- Vasculitis classification by vessel size
- Autoantibody patterns in connective tissue disease
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free